iRGD also induced tumour-blood transport of the secretory protein autotaxin in HCC mice, and of prostate-specific antigen (PSA) in mice with prostate cancer, suggesting that iRGD-induced transport may not be confined to classical tumour markers and extend beyond liver cancer. This evidence concerns the gene KLK3 and prostate cancer.